Lignans
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound class | Lignans — phenylpropanoid dimers formed by oxidative coupling of two coniferyl alcohol units |
|---|---|
| Representative members | Secoisolariciresinol (SDG), matairesinol, pinoresinol, lariciresinol, sesamin, arctigenin, schisandrin, magnolol, honokiol, macelignan |
| Primary sources | Flaxseed (Linum usitatissimum), sesame (Sesamum indicum), arni bark (Premna integrifolia), burdock, schisandra |
| Key applications | Phytoestrogenic activity via enterolignans, cardiovascular and lipid support, antioxidant, hormone-sensitive tissue research |
| Claim strength | Moderate for cardiometabolic markers and menopausal symptoms; Emerging for most member-specific claims |
| Typical form | Standardised extract declared as total lignans or as SDG content |
| Buy from Herbuno | Lignan Extract Powder · Flax Seed Extract · Black Sesame Seed Extract |
| Origin | Processed / Sourced from India |
| MOQ | R&D 100 g / 250 g (subject to stock) · Pilot batch 1–5 kg · Bulk 10 kg, 25 kg and above |
| Lead Time | Dispatch within 72 hrs from stock · fresh-batch production (typically 50 kg+): 10 working days |
| Documentation | CoA & MSDS standard with every lot; phytosanitary on request |
Name origin: From the Latin lignum, wood. The name was coined because these compounds were first characterised in woody tissue, where they contribute to lignification alongside the structurally related polymer lignin. The distinction matters and is routinely confused: lignin is an indigestible structural polymer, while lignans are low-molecular-weight dimers with biological activity. The two share a biosynthetic origin and almost nothing else.
Traditional use: Lignan-rich plants occupy a long place in materia medica without the lignans themselves having been the reason. Flaxseed appears in Ayurvedic, Greco-Roman and European practice as a demulcent and laxative, properties owed mainly to its mucilage rather than its lignans. Sesame is a staple of Ayurvedic oil preparations, where sesamin and sesamolin contribute the oxidative stability that made sesame oil valuable before refrigeration. Arni bark, Premna integrifolia, is one of the dashamula roots in Ayurveda and is a lignan source in its own right.
Research trajectory: Modern interest began in the 1980s when enterolactone and enterodiol were identified in human urine and traced back to dietary plant lignans converted by gut bacteria. That finding reframed the class: the compounds in food are largely precursors, and the biologically active species are microbial metabolites. Epidemiological work linking high enterolactone to lower cardiovascular and hormone-related cancer risk followed, and intervention trials have examined flaxseed lignans for lipids, blood pressure and menopausal symptoms with modest and mixed results.
Commercial source: Flaxseed is the dominant commercial source, with secoisolariciresinol diglucoside concentrated in the seed coat at levels far above other dietary sources, which is why defatted flax hull is the usual extraction feedstock. Sesame yields sesamin and sesamolin. Arni bark and burdock root are used in Ayurvedic-positioned material. Extracts are standardised either as total lignans or specifically as SDG, and the two conventions are not interchangeable, which is the main specification hazard in this category.
Evidence for Lignan Applications
The gut microbiome determines the response, and this is the central fact about lignans. Plant lignans such as SDG are largely inactive as ingested; colonic bacteria deglycosylate and demethylate them to enterodiol and enterolactone, which carry the phytoestrogenic activity. Conversion capacity varies several-fold between individuals depending on microbiota composition, and antibiotic exposure reduces it substantially. This means two people taking an identical dose can reach very different enterolactone concentrations, which explains much of the heterogeneity in the trial literature and limits what any fixed dose can promise. Claim strength: High.
Cardiometabolic effects are modest and reasonably consistent. Flaxseed lignan supplementation has shown small reductions in total and LDL cholesterol in meta-analysed trials, with some evidence for blood pressure reduction in hypertensive subjects. Effect sizes are small relative to pharmaceutical intervention and the trials vary in whether whole flaxseed, defatted meal or purified SDG was used — an important distinction, since whole flaxseed also supplies alpha-linolenic acid and soluble fibre, both of which independently affect lipids. Attributing whole-flaxseed results to lignans alone overstates the evidence. Claim strength: Moderate.
Phytoestrogenic activity is real, weak, and genuinely bidirectional. Enterolignans bind oestrogen receptors with affinity orders of magnitude below oestradiol, which means they can act as weak agonists in low-oestrogen states such as postmenopause and as competitive antagonists in high-oestrogen states. This is the same selective-modulator logic that applies to soy isoflavones. Trials of flaxseed for hot flushes have produced mixed results, with some showing reduction and others no better than placebo. The mechanism supports a cautious claim; the outcome data do not support a confident one. Claim strength: Moderate.
Member compounds differ enormously and should not inherit class-level evidence. Sesamin has its own literature on hepatic fatty acid oxidation and tocopherol sparing. Schisandrin is studied as a hepatoprotective adaptogen in a quite separate tradition. Honokiol and magnolol are neolignans with anxiolytic and anti-inflammatory research. Arctigenin has antiviral and anti-inflammatory work. These share a biosynthetic class and little else pharmacologically. A total-lignan extract standardised from flax cannot claim sesamin's lipid data or schisandrin's liver data. Claim strength: High for the distinction.
Hormone-sensitive cancer epidemiology is interesting and must stay epidemiological. Observational studies have associated higher enterolactone concentrations with reduced breast cancer incidence and improved survival, and the phytoestrogen mechanism offers a plausible explanation. These are cohort associations, subject to confounding by overall diet quality, and intervention trials with cancer endpoints do not exist. This is not a basis for any product claim, and the hormone-sensitivity question also means people with oestrogen-receptor-positive disease should take medical advice rather than be reassured by a label. Claim strength: Emerging.
The specification problem in this category is unusually severe. Extracts may be declared as total lignans, as SDG specifically, or as a flax hull extract with an unstated conversion basis, and the numbers differ by a large factor because SDG is a diglucoside with substantial non-lignan mass. A 20% total lignan extract and a 20% SDG extract are not the same material. Analytical methods also vary, with some hydrolysing conjugates before measurement and some not. Two certificates showing the same percentage can describe quite different products. Claim strength: High.
Sourcing lignans from Herbuno. We supply a standardised Lignan Extract Powder alongside flaxseed and black sesame extracts, and lignan-bearing Ayurvedic botanicals including arni bark.
Agree the declaration basis before you specify — total lignans versus SDG differ by a large factor at the same stated percentage, and this is where most disputes in this category originate. All lots ship with CoA and MSDS as standard; request a quotation for pilot or bulk volumes.
Dosage & Formulator Specification
The first decision is the declaration basis, because it governs everything downstream. Secoisolariciresinol diglucoside carries two glucose units, so SDG mass substantially exceeds the aglycone mass it delivers; an extract declared at 20% SDG and one declared at 20% total lignans are materially different products. Specify which convention applies, require the analytical method on the certificate, and convert to a common basis before comparing supplier quotations. Doses in the flaxseed lignan literature are commonly expressed as SDG, typically in the range of 50 to 600 milligrams daily.
Because the active species are microbial metabolites rather than the ingested compounds, response variability should be built into expectations rather than treated as a formulation failure. There is no practical way to predict an individual's conversion capacity at the point of sale. Co-formulating with prebiotic fibre is sometimes proposed on the rationale that it supports the converting microbiota; this is mechanistically reasonable and has not been demonstrated to raise enterolactone in controlled work, so it should be presented as a design rationale rather than a claim.
Lignan extracts handle reasonably well. They are stable to normal processing temperatures and across the pH range used in most formats, with the glycosides more stable than the aglycones. Flax-derived material carries a characteristic nutty, slightly bitter note and contributes colour, both of which scale with inclusion. Defatted flax hull extracts are lower in residual oil and therefore less prone to oxidative rancidity than whole-seed material, which is worth specifying for long shelf life. Sesame-derived material is an allergen in most jurisdictions and requires declaration.
For analytical control, specify HPLC with the hydrolysis step stated explicitly, since whether conjugates are hydrolysed before measurement changes the result substantially. Require the source species and plant part — flax seed coat, sesame seed, arni bark — since the lignan profile differs entirely between them and a total figure conceals that. Standard botanical specifications cover heavy metals, pesticide residues, residual solvents and microbiological limits. Cadmium is worth naming specifically for flax, which accumulates it. India-origin material ships with phytosanitary certification on request alongside CoA and MSDS.
One sequencing point for anyone building a range rather than a single product. Because the lignan class spans compounds with entirely separate pharmacologies, a formulator is usually better served deciding which specific lignan or which specific botanical the product is about, and sourcing to that, rather than specifying a total-lignan extract and discovering later that the claim they want belongs to a different member. Flax SDG, sesame sesamin and schisandra lignans are three different products with three different evidence bases and three different price points, and the word lignan on a specification sheet does not distinguish them.
Frequently Asked Questions — Lignans
Why do lignans affect people differently?
Because the compounds you ingest are mostly precursors. Colonic bacteria convert plant lignans such as SDG into enterodiol and enterolactone, which carry the activity, and conversion capacity varies several-fold between individuals with microbiota composition. Antibiotic exposure reduces it. Two people on an identical dose can reach very different enterolactone levels, which explains much of the inconsistency in the trial literature.
Is 20% total lignans the same as 20% SDG?
No, and this is the main specification hazard in the category. SDG is a diglucoside carrying two sugar units, so a substantial part of its mass is not aglycone. The two declarations differ by a large factor at the same stated percentage. Agree the basis and the analytical method before comparing quotations, not after.
Can a flax lignan extract claim sesamin's benefits?
No. Lignans are a biosynthetic class, not a pharmacological one. Sesamin has its own literature on fatty acid oxidation, schisandrin on hepatoprotection, honokiol and magnolol on anxiolytic effects. They share a structural origin and very little else. A flax-derived total-lignan extract carries flax lignan evidence only.
Do lignans help menopausal symptoms?
The mechanism supports a cautious claim and the outcome data are mixed. Enterolignans bind oestrogen receptors weakly, acting as mild agonists in low-oestrogen states. Trials of flaxseed for hot flushes have split between showing reduction and showing nothing beyond placebo. Moderate claim strength at best, and people with hormone-sensitive disease should take medical advice rather than rely on a label.
What should I test for in flax-derived material?
Cadmium specifically — flax accumulates it, and a general heavy metals panel may not be scrutinised closely enough. Also specify HPLC with the hydrolysis step stated, source species and plant part, and for defatted hull material the residual oil content, since that drives oxidative stability over shelf life.
Why source lignans from India?
Around 80% of raw nutraceutical ingredients originate in China and a qualified second origin is increasingly a continuity requirement. India is a major flaxseed and sesame producer with established extraction infrastructure, and it also gives access to lignan-bearing Ayurvedic botanicals such as arni bark that are not readily sourced elsewhere.